Best Practice & Research Clinical Haematology
Volume 21, Issue 2 , Pages 139-148 , June 2008

Vascular endothelium as ‘novel’ target of graft-versus-host disease

  • André Tichelli, MD

      Affiliations

    • Corresponding Author InformationCorresponding author. Department of Hematology, University Hospital, CH 4031 Basel, Switzerland. Tel.: +41 61 265 42 77; Fax: +41 61 265 44 50.
    • ,
  • Alois Gratwohl, MD

References 

  1. Gratwohl A, Baldomero H, Schmid O, et al. Change in stem cell source for hematopoietic stem cell transplantation (HSCT) in Europe: a report of the EBMT activity survey 2003. Bone Marrow Transplantation. 2005;36:575–590
  2. Gratwohl A, Baldomero H, Frauendorfer K, et al. Results of the EBMT activity survey 2005 on haematopoietic stem cell transplantation: focus on increasing use of unrelated donors. Bone Marrow Transplantation 0 AD;39:71–87.
  3. Shlomchik WD. Graft-versus-host disease. Nature Reviews. Immunology. 2007;7:340–352
  4. Massenkeil G, Nagy M, Neuburger S, et al. Survival after reduced-intensity conditioning is not inferior to standard high-dose conditioning before allogeneic haematopoietic cell transplantation in acute leukaemias. Bone Marrow Transplantation. 2005;36:683–689
  5. Biedermann BC, Sahner S, Gregor M, et al. Endothelial injury mediated by cytotoxic T lymphocytes and loss of microvessels in chronic graft versus host disease. Lancet. 2002;359:2078–2083
  6. Dumler JS, Beschorner WE, Farmer ER, et al. Endothelial-cell injury in cutaneous acute graft-versus-host disease. American Journal of Pathology. 1989;135:1097–1103
  7. Shulman HM, Sullivan KM, Weiden PL, et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. The American Journal of Medicine. 1980;69:204–217
  8. Sviland L, Sale GE, Myerson D. Endothelial changes in cutaneous graft-versus-host disease: a comparison between HLA matched and mismatched recipients of bone marrow transplantation. Bone Marrow Transplantation. 1991;7:35–38
  9. Ruutu T, Barosi G, Benjamin RJ, et al. Diagnostic criteria for hematopoietic stem cell transplant-associated microangiopathy: results of a consensus process by an International Working Group. Haematologica. 2007;92:95–100
  10. Shimoni A, Yeshurun M, Hardan I, et al. Thrombotic microangiopathy after allogeneic stem cell transplantation in the era of reduced-intensity conditioning: the incidence is not reduced. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation. 2004;10:484–493
  11. Uderzo C, Bonanomi S, Busca A, et al. Risk factors and severe outcome in thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation. Transplantation. 2006;82:638–644
  12. McDonald GB, Hinds MS, Fisher LD, et al. Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients. Annals of Internal Medicine. 1993;118:255–267
  13. Carreras E, Bertz H, Arcese W, et al. Incidence and outcome of hepatic veno-occlusive disease after blood or marrow transplantation: a prospective cohort study of the European Group for Blood and Marrow Transplantation. European Group for Blood and Marrow Transplantation Chronic Leukemia Working Party. Blood. 1998;92:3599–3604
  14. Cheuk DK, Wang P, Lee TL, et al. Risk factors and mortality predictors of hepatic veno-occlusive disease after pediatric hematopoietic stem cell transplantation. Bone Marrow Transplantation. 2007;
  15. Majhail NS, Parks K, Defor TE, et al. Diffuse alveolar hemorrhage and infection-associated alveolar hemorrhage following hematopoietic stem cell transplantation: related and high-risk clinical syndromes. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation. 2006;12:1038–1046
  16. Wojno KJ, Vogelsang GB, Beschorner WE, et al. Pulmonary hemorrhage as a cause of death in allogeneic bone marrow recipients with severe acute graft-versus-host disease. Transplantation. 1994;57:88–92
  17. Spitzer TR. Engraftment syndrome following hematopoietic stem cell transplantation. Bone Marrow Transplantation. 2001;27:893–898
  18. Gorak E, Geller N, Srinivasan R, et al. Engraftment syndrome after nonmyeloablative allogeneic hematopoietic stem cell transplantation: incidence and effects on survival. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation. 2005;11:542–550
  19. Colby C, McAfee S, Sackstein R, et al. Engraftment syndrome following myeloablative conditioning therapy and HLA-matched bone marrow transplantation (BMT) for hematological malignancy. Blood. 2000;96:520a
  20. Deeren DH, Zachee P, Malbrain ML. Granulocyte colony-stimulating factor-induced capillary leak syndrome confirmed by extravascular lung water measurements. Annals of Hematology. 2005;84:89–94
  21. Nurnberger W, Willers R, Burdach S, et al. Risk factors for capillary leakage syndrome after bone marrow transplantation. Annals of Hematology. 1997;74:221–224
  22. Gyger M, Rosenberg A, Shamy A, et al. Vascular leak syndrome and serositis as an unusual manifestation of chronic graft-versus-host disease in nonmyeloablative transplants. Bone Marrow Transplantation. 2004;35:201–203
  23. Cahill RA, Spitzer TR, Mazumder A. Marrow engraftment and clinical manifestations of capillary leak syndrome. Bone Marrow Transplantation. 1996;18:177–184
  24. Talvensaari KK, Lanning M, Tapanainen P, et al. Long-term survivors of childhood cancer have an increased risk of manifesting the metabolic syndrome. The Journal of Clinical Endocrinology and Metabolism. 1996;81:3051–3055
  25. Boivin JF, Hutchison GB, Lubin JH, et al. Coronary artery disease mortality in patients treated for Hodgkin's disease. Cancer. 1992;69:1241–1247
  26. Taskinen M, Saarinen-Pihkala UM, Hovi L, et al. Impaired glucose tolerance and dyslipidaemia as late effects after bone-marrow transplantation in childhood. Lancet. 2000;356:993–997
  27. Baker KS, Ness KK, Steinberger J, et al. Diabetes, hypertension and cardiovascular events in survivors of hematopoietic cell transplantation: a report from the bone marrow transplant survivor study. Blood. 2007;109:1765–1772
  28. Couriel DR, Saliba R, Escalon MP, et al. Sirolimus in combination with tacrolimus and corticosteroids for the treatment of resistant chronic graft-versus-host disease. British Journal of Haematology. 2005;130:409–417
  29. Tichelli A, Bucher C, Rovo A, et al. Premature cardiovascular disease after allogeneic hematopoietic stem-cell transplantation. Blood. 2007;110:3463–3471
  30. Kapadia SR, Ziada KM, L'Allier PL, et al. Intravascular ultrasound imaging after cardiac transplantation: advantage of multi-vessel imaging. The Journal of Heart and Lung Transplantation: the Official Publication of the International Society for Heart Transplantation. 2000;19:167–172
  31. Rahmani M, Cruz RP, Granville DJ, et al. Allograft vasculopathy versus atherosclerosis. Circulation Research. 2006;99:801–815
  32. Kasiske BL, Guijarro C, Massy ZA, et al. Cardiovascular disease after renal transplantation. Journal of the American Society of Nephrology. 1996;7:158–165
  33. Cailhier JF, Laplante P, Hebert MJ. Endothelial apoptosis and chronic transplant vasculopathy: recent results, novel mechanisms. American Journal of Transplantation: Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2006;6:247–253
  34. Wojcik D, Socié G, Rapala M, et al., on behalf of the EBMT Late Effect Working Party  Late vascular complications after haematopoietic stem cell transplantation: a retrospective multicentre study of the Late Effect Working Party EBMT. Bone Marrow Transplantation. March 2006;37(Suppl. 1):269
  35. Tesfamariam B, DeFelice AF. Endothelial injury in the initiation and progression of vascular disorders. Vascular Pharmacology. 2007;46:229–237
  36. Goon PK, Boos CJ, Lip GY. Circulating endothelial cells: markers of vascular dysfunction. Clinical Laboratory. 2005;51:531–538
  37. Pihusch V, Rank A, Steber R, et al. Endothelial cell-derived microparticles in allogeneic hematopoietic stem cell recipients. Transplantation. 2006;81:1405–1409
  38. Salat C, Holler E, Kolb HJ, et al. Endothelial cell markers in bone marrow transplant recipients with and without acute graft-versus-host disease. Bone Marrow Transplantation. 1997;19:909–914
  39. Biedermann BC, Tsakiris DA, Gregor M, et al. Combining altered levels of effector transcripts in circulating T cells with a marker of endothelial injury is specific for active graft-versus-host disease. Bone Marrow Transplantation. 2003;32:1077–1084
  40. Matsuda Y, Hara J, Osugi Y, et al. Serum levels of soluble adhesion molecules in stem cell transplantation-related complications. Bone Marrow Transplantation. 2001;27:977–982

PII: S1521-6926(08)00004-2

doi: 10.1016/j.beha.2008.02.002

Best Practice & Research Clinical Haematology
Volume 21, Issue 2 , Pages 139-148 , June 2008

Article Tools

* Image Usage & Resolution